Thank you for submitting your manuscript for consideration by the EMBO Journal. I apologise that it has taken longer than anticipated to get back to you with a decision I am disappointed with this as I wanted to expedite the review process. I have now received the final report from the two referees who have evaluated your manuscript and I enclose their reports below.
Both referees find the study to be potentially interesting, however, the referees provide mixed recommendations. Referee #1 finds that the manuscript is too preliminary for publication in The EMBO Journal and raises a number of valid and important concerns. This referee finds that there is insufficient data to directly link CUL4 to PRC2 pathway and also requires significant further developmental and genetic analysis of the mutant alleles. Referee #2 is more positive but does ask for further molecular consequences of the CUL4-MSI1 interaction. After reading these reports it is clear that a significant amount of work is required to satisfy referee #1 who currently finds the study not suitable for The EMBO Journal. If you are able to easily and quickly address these concerns please contact me and I would be willing send the manuscript back to this referee for his/her comments. However, I appreciate that there is a lot of work requested and currently this goes beyond a normal 3 month round of revision that is allowed by the journal, and given that there is a competing manuscript, in my opinion based on these reports it may be in your best interest to pursue publication elsewhere at this stage. Based upon this initial review, I am afraid, I see little choice but to come to the conclusion that we cannot offer to publish this study in the EMBO Journal.
However, as mentioned above given the potential interest if you are able to extend the study experimentally as suggested we would be willing to look at the manuscript once more. I would like to stress that the novelty of the study would be assessed once more when the manuscript is resubmitted and while I would try to go back to the original referees depending on their availability this could potentially entail the selection of new additional referee(s). If you decide to thoroughly expand the manuscript and submit an improved version to the EMBO Journal, please make sure to mention the initial manuscript number to allow efficient handling. However as mentioned at this stage of analysis, I am sorry to have to disappoint you.
Thank you for the opportunity to consider your manuscript. I am sorry we cannot be more positive on this occasion, but we hope nevertheless that you will find our referees' comments helpful. We also hope that this negative decision does not prevent you from considering our journal for publication of your future studies.
Yours sincerely, Editor
The EMBO Journal
Referee #1 (Remarks to the Author):
The report by Dumbliauskas et al is a study of the effect of loss of CUL4 activity on seed development and shows that CUL4 and its associated partner DDB1a interact with the WD40 domain protein MSI1. Besides the protein interaction, the data presented remains preliminary and the authors draw unsubstantiated conclusions relative to the interaction between the CUL4 and PRC2 pathway. In its present form the work is not ready for publication as the involvement of all the likely genetic pathways has not been tested and the data provided are not all of sufficient quality. The authors will find below detailed comments and guidelines to help them to improve the quality of the data and a detail of the various other working hypotheses that they should pursue in order to be able to reach conclusions relative to the pathway -not PRC2-actually regulated by CUL4 and MSI1
The authors show that 1. MSI1 interacts with DDB1A using several strategies and that CUL4 and MSI1 can be coimmunoprecipitated. The authors conclude that CUL4, DDB1 and MSI1 form a protein complex. This conclusion is not directly supported and would require isolation of the whole protein complex. With the data available the authors should limit their conclusions to the demonstrated interactions between MSI1 and CUL4 and MSI1 and DDB1a and might speculate the existence of a complex only in the Discussion.
2. The authors identify two mutant alleles cul4-2 and cul4-3. They localize the T-DNA insert responsible for the mutation and show downregulation of the level of CUL4 transcript. These mutations cause seed lethality and are thus distinct from the cul4-1 allele, which can be obtained as homozygote. However the authors do not provide a direct comparison between the three alleles and it is difficult to understand the various phenotypes observed for each allele while the molecular defects are similar. The authors should quantify the amount of CUL4 messenger produced and provide hypotheses. This is an important point as the three alleles are used in different combination in the study.
3. The genetic analysis of the defects associated with the mutant alleles cul4-2 and cul4-3 is confusing. The authors report reduced transmission by both gametes associated with cul4-2. The authors should also analyze the cul4-3 TE. Reduced TE should logically result either in a reduction of the proportion of developing seeds or cause a parental effects, which in addition to the embryo lethal effect, should increase the ratio of abnormal seed development above 1:3, which is not the case.
4. The authors provide a very limited analysis of the cause of embryo lethality. The quality of the data is below what should be expected for publication in EMBO Journal. A developmental time course must be provided. Markers should be used to determine with accuracy the embryo defects. Fig3A is not informative and the quality of the cytological analysis provided by DIC optic in Fig3B is not sufficient. Detailed analysis of the phenotype in the endosperm should be provided since this is the primary target of PRC2 function in the seed.
5. Since the authors attempt to link the function of CUL4 with the Polycomb pathway they should focus on the parental effects of cul4 and ddb1a, which are typically associated with defects in this pathway, and determine with precision the origin of the reduced TEs. Preliminary data are reported in sup Fig4 from crosses between cul4-1 and cul4-2 alleles but it is not clear why the authors use this allele combination.
6. The authors do not observe autonomous seed development in absence of CUL4.
7. The authors then report that ectopic MEA expression in vegetative tissues and from the paternal allele in backgrounds where CUL4 function is compromised. Although most of the results are convincing, the authors use various combinations of cul4 alleles and obtain the stronger effects when the weaker allele cul4-1 is used, which is difficult to explain.
8. The loss of CUL4 function did not affect the expression of PHE1, which is also controlled by the Polycomb pathway.
9. The Discussion does not reflect the information that one can derive from the data.
The authors claim that "Here we establish for the first time a link between an ubiquitin E3 ligase and a PRC2 complex.' However, neither the phenotype of seeds observed the cul4 mutant nor the absence of effect of cul4 mutation on PHE1 expression support this claim. A true interaction with PRC2 should lead to maternal effects on endosperm development and not an early embryo lethality as observed. Autonomous seed development would be also expected. The authors do not show that MEA ectopic expression is caused by the loss of H3K27 2/3Me marks, which would be necessary to argue in favor of a PRC2 pathway.
In addition the CUL4 interaction with a PRC2 complex is predicted to lead to its targeted degradation. Logically the absence of CUL4 function should lead to hyperactivity of PRC2, which is opposite to the effect observed on MEA expression.
The authors provide solid evidence showing that MSI1 interacts with DDB1a and possibly with CUL4. MSI1 acts in multiple other pathways including Chromatin assembly, Retinoblastoma and others. The authors should test the effects of CUL4 in these other pathways, which should eventually lead them to better understand the function of the MSI1-DDB1a interaction.
Referee #2 (Remarks to the Author):
CUL4-containing ubiquitin ligases (CRL4) are a recently identified family of E3 ligases with various roles in eukaryotes. Here, MSI1, a component of the FIS-PRC2 polycomb repressor complexes (and other multiprotein complexes, such as CAF-1) is found to interact with CUL4 and DDB1, as part of a multimeric complex. Loss of CUL4 and DDB1 function leads to loss of parental imprinting of MEA, a PRC2 target. Also, MEA mRNA and protein levels are altered in a cul4 mutant background. This is the first evidence of a link between and E3 ligase and a PRC2 component, suggesting a role of ubiquitylation in gene repression. This is an interesting story, which certainly extends previous observations of a link between an E3 ligase and PRC1 to the PRC2 complexes. The interaction studies are convincing (but see also below). However, I think that description of results, which is sometimes a bit confusing, at least, not very fluid, could be considerably improved. It is not fully clear whether the focus of the study is the phenotypic description of cul4 and ddb1 mutants, the interactions with MSI1, or their effect on MEA. I made the exercise of jumping from the end of the second section in Results to the beginning of the fifth section without feeling that, in its present form, I had lost a significant part of the story. In fact, the Discussion is virtually restricted to these results. Comments 1. The existence of two DDB1 genes should be explained (or appropriately referenced) the first time of appearance. 2. Fig. 2B . It is formally correct to show the control and the experiments in the same gel.
3. Fig. 2D . The quality of the IP-WB data presented needs some improvement. The increases are not really convincing.
4. What are the molecular consequences of the CUL4-MSI1 interaction? Is MSI1 ubiquitylated, or not, in the PRC2 complexes? Other possible targets? 5. S1B. Also the RT-PCR data presented needs improvement, the bands are hardly visible.
6. Page 9, first paragraph on MEA mRNA and protein levels. Figs. 5A and 5B are not correctly called in the text. What is the most functionally relevant outcome in cul4-2 mutants: the lack of decay in MEA level or the lack of accumulation at 0 DAP? 7. The writing and depth of the Discussion section can be considerably improved. It does not deal comprehensively with topics touched in the work: e.g., implications on PRC2 complexes, the MSI1 part of the manuscript, among others.
Additional correspondence from author 27 April 2010
Thank you for your reply. I went through the reviews and discussed with some colleges here at IBMP. Thus our feeling is that it is worth to resubmit the paper to EMBO J, of course if you allow us to do so. However, based on the requests, we would need an extension of at least 2 months. The risk is that our competitors get their paper out before us, but there is always a part of risk in everything. Also submission to another high profile journal means another additional 2-3 months reviewing process with different requests from the reviewers.
Coming back to the reviews, I am pleased that both reviewers consider the work of potential interest and we can certainly improve the CUL4-PRC2 link as requested by providing some additional experiments.
However I am puzzled by some comments/requests of Rev 1, which I do not really understand.
1. The Reviewer recognizes our interaction studies between "MSI1 and CUL4" and "MSI1 and DDB1", what seems missing is between CUL4 and DDB1 (if I understand well). But this is published (in three different papers including 2 Plant Cell papers).
2. I do not understand his point2. What we show is that two alleles are null mutants, which are not viable as is also the double ddb1a ddb1b mutant. The cul4-1 is a knockdown, so I don't see what and how we should compare them.
3. His points 5 and 7 are unclear. Why we use "the cul4-1 cul4-2" allele combination? I think it is obvious that allowing seed development to go a step further allows a better characterization of MEA expression in the endosperm. What the reviewer probably overlooked is that CUL4 in plants, as in metazoans, makes multiple CRL4 E3 complexes also involved in cell cycle regulation, and null alleles blocks endosperm development at a very early stage.
4. The reviewer states that: "we have not shown that MEA ectopic expression is caused by the loss of repressive histone marks". I am sorry but this is shown in Figure 5D .
Anyway, if you allow us to resubmit our paper with an extension period of 1-2 months, we would certainly take this challenge.
Additional correspondence (from editor) 27 May 2010
Sorry for the late response, I am currently and over the next month or so quite often out of the office. I am happy to extend the deadline for submission of a revised manuscript by an additional 2 months. I realize that the referees ask for a large number of further experiments and this will take extra time, however, it is essential that the important additions to the study are made. Along these lines I would like to point out when assessing novelty of a study, EMBO J only takes into consideration studies published at the date of submission and not studies published during the revision period, and in exchange we expect authors to make a serious attempt at resolving important issues raised by the referees that are directly related to the study.
I appreciate that Referee #1 raises a large number of issues and while the revised version of the manuscript will be sent back to this referee I will also seek additional independent input specifically on the comments raised. Please feel free to contact me if you have any further issues to discuss.
Resubmission 06 November 2010
Responses to Referee comments:
The report by Dumbliauskas et al is a study of the effect of loss of CUL4 activity on seed development and shows that CUL4 and its associated partner DDB1a interact with the WD40 domain protein MSI1. Besides the protein interaction, the data presented remains preliminary and the authors draw unsubstantiated conclusions relative to the interaction between the CUL4 and PRC2 pathway. In its present form the work is not ready for publication as the involvement of all the likely genetic pathways has not been tested and the data provided are not all of sufficient quality. The authors will find below detailed comments and guidelines to help them to improve the quality of the data and a detail of the various other working hypotheses that they should pursue in order to be able to reach conclusions relative to the pathway -not PRC2-actually regulated by CUL4 and MSI1
The authors show that
MSI1 interacts with DDB1A using several strategies and that CUL4 and MSI1 can be coimmunoprecipitated. The authors conclude that CUL4, DDB1 and MSI1 form a protein complex. This conclusion is not directly supported and would require isolation of the whole protein complex. With the data available the authors should limit their conclusions to the demonstrated interactions between MSI1 and CUL4 and MSI1 and DDB1a and might speculate the existence of a complex only in the Discussion.
Response: As MSI1 interacts with DDB1 and since DDB1 interacts with CUL4 as shown in many papers (S. pombe, Drosophila, fly, mouse human..), including our work in Arabidopsis (Bernhardt et al., 2006, Plant J. 47, 591-603) and others, it seems unlikely that these proteins are not part of the same complex. Nevertheless, we modified the text on page 5.
The authors identify two mutant alleles cul4-2 and cul4-3. They localize the T-DNA insert responsible for the mutation and show downregulation of the level of CUL4 transcript. These mutations cause seed lethality and are thus distinct from the cul4-1 allele, which can be obtained as homozygote. However the authors do not provide a direct comparison between the three alleles and it is difficult to understand the various phenotypes observed for each allele while the molecular defects are similar. The authors should quantify the amount of CUL4 messenger produced and provide hypotheses. This is an important point as the three alleles are used in different combination in the study.
Response: We do not understand the concern of the reviewer regarding the cul4 mutant alleles as the molecular defect cannot be similar between cul4-1 and either cul4-2 or cul4-3. The cul4-1 is a T-DNA insertion in an intron, which nevertheless gets spliced and allows the production of the CUL4 protein, though at a lower level than in a wild-type situation (see Bernhardt et al., 2006, Plant J. 47, 591-603) . Thus, the published cul4-1 mutant allele is hypomorphic and, for this reason, we searched null mutations and identified the cul4-2 and cul4-3 alleles. Both alleles are embryo lethal and show the same phenotype (Table 1 and 2; Figure 3 ). Combining the strong allele with the hypomorph gave an intermediate phenotype that was instrumental in our studies. The amount of CUL4 mRNA in the cul4-2 and cul4-3 heterozygote plants can be seen in Figure S1 . The two panels are from the same RNA gel showing a similar reduction. It is noteworthy that the cul4-2 allele was not correctly indicated in the text on page 9, but correctly labelled on Fig 5B. We apologize as this may have raised some confusion but it is now corrected.
The genetic analysis of the defects associated with the mutant alleles cul4-2 and cul4-3 is confusing. The authors report reduced transmission by both gametes associated with cul4-2. The authors should also analyze the cul4-3 TE. Reduced TE should logically result either in a reduction of the proportion of developing seeds or cause a parental effects, which in addition to the embryo lethal effect, should increase the ratio of abnormal seed development above 1:3, which is not the case.
Response: The gametophytic effects of the cul4-2 mutation is very weak. This would lead to only a slight reduction in the Hyg-resistant seedlings scored in Table 1 and indeed this is what we observe (we are slightly below the 2/3 of Hyg-resistant seedlings expected for a strict embryo lethal). As requested by the reviewer, we also analysed the cul4-3 TE and found very similar results as for the cul4-2 mutant (see new Table1): a weak reduction in the T-DNA transmission through both male and female gametes.
The authors provide a very limited analysis of the cause of embryo lethality. The quality of the data is below what should be expected for publication in EMBO Journal. A developmental time course must be provided. Markers should be used to determine with accuracy the embryo defects. Fig3A is not informative and the quality of the cytological analysis provided by DIC optic in Fig3B is not sufficient. Detailed analysis of the phenotype in the endosperm should be provided since this is the primary target of PRC2 function in the seed.
Response: We followed the recommendation of the reviewer and provided a developmental time course as requested. The higher resolution images we provide clearly describe the defects observed in mutant seeds, in particular in the endosperm.
Since the authors attempt to link the function of CUL4 with the Polycomb pathway they should focus on the parental effects of cul4 and ddb1a, which are typically associated with defects in this pathway, and determine with precision the origin of the reduced TEs. Preliminary data are reported in sup Fig4 from crosses between cul4-1 and cul4-2 alleles but it is not clear why the authors use this allele combination.
Response: The gametophytic effects of the cul4 mutations are very weak and thus it would be difficult to determine with precision their origins. Concerning the reason to cross the hypomorphic cul4-1 mutant with the null mutant is to obtain cul4 mutant seeds that arrest at a later stage and to allow MEA-YFP detection in the endosperm. As indicated, in the cul4 null mutants endosperm division is strongly reduced, most likely because of the involvement of CUL4 in cell cycle function.
The authors do not observe autonomous seed development in absence of CUL4.
Response: We reinvestigated this issue, and actually we observed endosperm initiation in the absence of fertilisation (however with a low penetrance similar to that of mea mutants). This data is now added in the manuscript (Supplemental Figure S5) . We also discuss why we believe cul4 mutants do not entirely phenocopy the fis class mutants. The main reason may be that CUL4 likely partizipates in dozens of CRL4s E3 complexes, some of which may be involved in cell cycle regulation (see Roodbarkelari et al., 2010, PNAS 107: 15275-15280) . Thus, it is unlikely that the endosperm can strongly over-proliferate as observed in fis mutants. This is reminiscent of CUL1, which is also embryo lethal, but the analysis of hypomorphic mutations helped several labs to highlight its important function in various hormonal pathways including auxin responses.
The authors then report that ectopic MEA expression in vegetative tissues and from the paternal allele in backgrounds where CUL4 function is compromised. Although most of the results are convincing, the authors use various combinations of cul4 alleles and obtain the stronger effects when the weaker allele cul4-1 is used, which is difficult to explain.
Response: By checking the text of the previous manuscript, we understand the Reviewer's concern. Indeed on page 9 (of the previous version), it is not the weak cul4-1 allele that was used, but the null mutation (cul4-2). This was correct in the previous Fig5B, but not in the text. We apologies for this mistake, which created some confusion (see also point 2). This has now been corrected.
The loss of CUL4 function did not affect the expression of PHE1, which is also controlled by the Polycomb pathway.
Response: We agree that this was an intriguing result. Here, we provid additional experiments (novel Figure 5 and Figure 6 ), which show that PHE1, similarly to MEA looses its repressive H3K27me3 marks, which supports a function of CUL4 also on the PHE1 locus. It is noteworthy that PHE1 imprinting also involves DNA-methylation. Hence, the 3' region of PHE1 containing tandem repeats must not be methylated for a stable maternal repression of the gene (Makarevich et al., 2008) . According to our observations, this 3' region seems to be sufficient to maintain maternal PHE1 repression in the cul4 background, but not in fis class mutants as previously published, which can be explained by a lower and latter effect on H3K27me3 marks (novel Figure 5) . Moreover, when this 3' region is absent in the PHE1-GUS construct, we observed a higher expression of the maternal PHE1-GUS reporter transgene, similar to what occurs in the msi1 mutant. This novel data has been included and discussed in the revised version of the manuscript.
The Discussion does not reflect the information that one can derive from the data.
Response: The discussion has been modified and largely extended. Authors have addressed satisfactorily most of the points contained in my review. However, there is one point that still requires further discussion. This refers to point 6 in my review regarding former Fig. 5 describing levels of MEW mRNA and protein (Fig. 7 in the revised version) . It is evident from the gels shown that at 0 DAP the MEA-YFP band in wt is much stronger than in the cul4-2 background. Thus, it seems that the cul4-2 mutation affects the levels of MEA-YFP and this needs a detailed discussion. Regarding the panels containing the mRNA levels, the current calculations of relative levels allow the comparison relative to 0 DAP, but not the comparison of cul4-2 mutant vs. wt. In other words, what is the outcome if all value are made relative to wt, time 0 DAP? Is the difference in MEA-YFP protein amount at time 0 DAP in wt and cul4-2 mutant simply reflecting differences in mRNA levels? The level of MEA-YFP protein in cul4-2 mutants seems very similar to that in wt 1 or 2 DAP. Does this represent a kind of background level?
Minor point. Fig. 3 Response: As mentioned by this Referee, the actual Figure 7 does not allow a direct comparison of the transcript levels between wild type and mutant. Therefore we provide in "referee-only" supplementary material a comparison between Col-0 and cul4-2 (where Col-0 was normalized to 1 at the time points 0 DAP). It appears that the transcript level of MEA-YFP in the cul4-2 mutant is significantly lower than for Col-O. One possibility is that this results from a partial silencing of the transgene in this mutant background. This is further supported by the fact that it was also difficult to maintain the MEA-YFP transgene expression in the cul4-1 mutant background. Moreover the apparent constitutive level of MEA-YFP protein in cul4-2 reflects the transcript levels, but is not a background signal as in Col-0 this signal totally disappears at 3DAP, which is not the case in the cul4-2 mutant.
To clarify this point, we have modified the text in the result section (page 11):
"It is noteworthy that the pMEA::MEA-YFP transgene was partially silenced in the cul4-2
background. This phenomenon, at least in part, could explain the lower MEA-YFP protein content detected in the mutant ( Figure 7B ). Since MEA transcript levels did not decay in the cul4-2 mutant Response: The seeds shown in panels A, C and E are those looking similar to a wild type situation, though they are from siliques of homozygous cul4-1 mutant plants. We modified the Figure 3 legend to clarify this point. We believe that this point was clear in the text (page 5). 
